Calcitriol and Robaxin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Calcitriol (calcitriol) and Robaxin (methocarbamol). Common drug interactions include surgery among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Calcitriol and Robaxin. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.
What is Calcitriol?
Calcitriol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 24,162 Calcitriol users. Check the latest studies of Calcitriol.
What is Robaxin?
Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
41 people who take Calcitriol and Robaxin together, and have interactions are studied.

What are the common drug interactions of Calcitriol and Robaxin, by gender? *:
female:
- Surgery
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Pruritus (severe itching of the skin)
- Anxiety
- Pain in extremity
- Joint stiffness
- Livedo reticularis (a lace-like purplish discoloration of the skin)
- Mobility decreased (ability to move is reduced)
- Muscular weakness (muscle weakness)
male:
- Chronic kidney disease
- Renal disorder (kidney disease)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Spinal cord compression
- Wheezing (a high-pitched whistling sound made while you breath)
- Renal failure (kidney dysfunction)
- Ankylosing spondylitis (type of arthritis affecting the spine)
- Death
- Drug intolerance (drug sensitivity)
- Fall
What are the common drug interactions of Calcitriol and Robaxin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Cardiac arrest
- Contusion (a type of hematoma of tissue in which capillaries)
- Decreased appetite
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dizziness
- Dyspepsia (indigestion)
- Emotional disorder
- Haemorrhage intracranial (bleeding within the skull)
- Hypoaesthesia (reduced sense of touch or sensation)
- Malaise (a feeling of general discomfort or uneasiness)
50-59:
- Pruritus (severe itching of the skin)
- Anxiety
- Joint stiffness
- Livedo reticularis (a lace-like purplish discoloration of the skin)
- Mobility decreased (ability to move is reduced)
- Muscular weakness (muscle weakness)
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Pain in extremity
- Peau d'orange (orange peel skin)
- Scab (a hard coating on the skin formed during the wound healing)
60+:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Diarrhoea
- Infection
- Knee arthroplasty
- Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
- Spinal cord compression
- Renal impairment (severely reduced kidney function)
What are the existing conditions these people have? *
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 19 people, 46.34%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 39.02%
- Pain: 10 people, 24.39%
- Diabetes: 9 people, 21.95%
- High Blood Pressure: 9 people, 21.95%
- Infection: 9 people, 21.95%
- Indigestion: 8 people, 19.51%
- Hypotension (abnormally low blood pressure): 7 people, 17.07%
- Anaemia (lack of blood): 7 people, 17.07%
- Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 17.07%
* Approximation only. Some reports may have incomplete information.
Do you take Calcitriol and Robaxin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Calcitriol (24,162 reports)
- Robaxin (9,109 reports)
Browse all drug interactions of Calcitriol and Robaxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Calcitriol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Robaxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Calcitriol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Robaxin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on calcitriol and methocarbamol (the active ingredients of Calcitriol and Robaxin, respectively), and Calcitriol and Robaxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mononeuritis and drugs of ingredients of acetaminophen; hydrocodone bitartrate - now
- Skin Infection Aggravated and drugs of ingredients of liraglutide - now
- Amlodipine and Brain Injury for Women aged 40-49 - now
- Amlodipine and Head Trauma for Women aged 40-49 - now
- Could Ventolin cause Vomiting Aggravated? - 2 seconds ago
- Cholestasis and drugs of ingredients of atorvastatin calcium; ezetimibe - 3 seconds ago
- Amlodipine and Head Injury for Girls aged 10-19 - 5 seconds ago
- Amlodipine and Contusion for Girls aged 10-19 - 6 seconds ago
- Amlodipine and Brain Injury for Girls aged 10-19 - 6 seconds ago
- Amlodipine and Head Trauma for Girls aged 10-19 - 6 seconds ago